Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • United States DEA hearings begin on proposal to reschedule cannabis ...
  • Switzerland Basel extends cannabis pilot project and includes new products ...
  • Czech Republic Decree simplifying medical cannabis prescription process proposed ...
  • Brazil Anvisa puts review of medical cannabis regulation on agenda ...
  • Denmark Trial scheme to prescribe medical cannabis made permanent ...
  • Europe ECR proposes including cannabis in EU goal to be tobacco-free by 2040 ...
  • Philippines DDB and PDEA open to reclassifying cannabis as less dangerous ...
  • Costa Rica Court rules bill regulating recreational cannabis is unconstitutional ...
  • Australia Senate rejects Greens’ cannabis legalisation bill ...
  • Europe EU Parliament approves new Commission ...
  • Philippines Senator plans to bring CBD laws in line with international recommendations ...
  • New Zealand Medicinal Cannabis Agency verifies new cannabis flower for tea ...
View all
News analysis

Cann Group teams up with Emyria to develop pharmacy grade CBD capsules

Written by || 21st April 2021 || News analysis | Companies | Health and science | Technology and innovation | GeographiesAustralasia Australia

Australian medicinal cannabis firm Cann has moved quickly to maximise the benefits of its CBD Gelpell capsule technology by entering into a collaboration deal with healthcare technology firm Emyria
Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber

Login

Keep me logged in


Author default picture

Lorraine Mullaney

Senior writer
Lorraine is responsible for writing news analysis and assisting with copy-editing. Lorraine is a copywriter and editor who has written and edited words for a wide range of audiences, from local community newspapers to consumer magazines and trade websites.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.